Abstract
Ionotropic glutamate receptors (GluRs) function as an excitatory transmitter system in the human brain, particularly in learning and memory. Development of small molecules that are capable of selectively potentiating the ion channel activity of AMPA-subtype GluRs holds promise for potential new treatment of neurodegenerative diseases such as Alzheimer’s. In working towards this goal, we obtained main-chain nuclear magnetic resonance (NMR) assignments of the extracellular ligand-binding domain of GluR2 that enables us to investigate receptor-ligand interactions in physiological conditions at atomic detail. With NMR structure-based methods, chemical compounds that can selectively modulate the ion chancel activity of GluR2 alone or synergistically with glutamate or kainate were identified. Our NMR structural analysis of GluR2 S1S2 further reveals that the regions of the receptor dimer interface exhibit distinct conformational dynamics, which we hypothesize to be linked to receptor functions in interactions with an agonist or antagonist. This coupling of ligand binding to receptor dimerization, gating, and desensitization may serve as an in vitro biophysical parameter to evaluate potential biological effects of the chemical ligands being developed here.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Burnashev N., Monyer H., Seeberg P. H., and Sakmann B. (1992) Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8, 189–198.
Hajduk P. J., Measdows R. P., and Fesik S. W. (1999) NMR-based screening in drug discovery. Q. Rev. Biophys. 32, 211–240.
Hollmann M. and Heibemann S. (1994) Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31–108.
Kuusinen A., Arvola M., and Keinanen K. (1995) Molecular dissection of the agonist binding site of an AMPA receptor. EMBO J. 14, 6327–6332.
Lee J.-M., Zipfel G. J., and Choi D. W. (1999) The changing landscape of ischaemic brain injury mechanisms. Nature 399, A7-A14.
Moore J. M. (1999) NMR screening indrug discovery. Curr. Opin. Biotechnol. 10, 54–58.
Morrison J. H. and Hof P. R. (1997) Life and death of neurons in the aging brain. Science 278, 412–419.
Pellegrini-Giampietro D. E., Gorter J. A., Bennett M. V. L., and Zukin R. S. (1997) The GluR2 (GluR-B) hypothesis: Ca2+-permeable AMPA receptors in neurological disorders. Trends Neurosci. 20, 464–470.
Seeburg P. H. (1993) The TINS/TiPS lecture. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16, 359–365.
Sun Y., Olson R., Horning M., Armstrong N., Mayer M., and Gouaux E. (2002) Mechanism of glutamate receptor desensitization. Nature 417, 245–253.
Weinstein H. and Osman R. (1989) Interaction mechanisms at biological targets: implications for design of serotonin receptor ligands, in Computer-Aided Molecular Design, Richards W. G., ed. IBC Technical Services, London, UK.
Yamazaki T., Lee W., Arrowsmith C. H., Mahandiram D. R., and Kay L. E. (1994) A suite of triple resonance NMR experiments for the backbone assignment of 15N, 13C, 2H labeled proteins with high sensitivity. J. Am. Chem. Soc. 116, 11655–11666.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zeng, L., Chen, K., Muller, M. et al. Structure-based functional design of chemical ligands for AMPA-subtype glutamate receptors. J Mol Neurosci 24, 81–84 (2004). https://doi.org/10.1385/JMN:24:1:081
Issue Date:
DOI: https://doi.org/10.1385/JMN:24:1:081